The use of antibiotics in Italy: National Report - Year 2020

On 10 March 2022, the National Report on the use of antibiotics in Italy -2020', concerning antibiotics for human use, was presented on AIFA's YouTube channel to monitor consumption and expenditure trends in Italy and identify areas of potential inappropriate use.

A morning of intense work in which we participated with interest.
We have produced a summary in graphic format with the highlights that seem to us most relevant to the governance of this type of drug.

In particular, the Report shows that:

- 3 out of 10 citizens received at least one antibiotic prescription in 2020. Utilisation is highest in the paediatric segment and in the over-80s.
- In 2020, antibiotics accounted for 1.2% of consumption and 3% of SSN expenditure (692 million) in Italy. Overall consumption is decreasing (-18.2%), but higher than the European average.
- Prices that are too low can be an incentive to buy: we need to think about policies on new antibiotics or separating price from industry revenues or find new ways to approach this aspect that has contributed to widespread use.

Budget Law 2024

On 31 October 2023, the 'stamped' text of the Budget Law 2024 arrived in Parliament for the final approval process. Pharma Value analysed

AIFA meets

On 12 September, the 'AIFA Incontra' initiative was held at the agency's institutional headquarters in Via del Tritone, a new way of dialogue in transparency

Special Commission Update No. 3 - Towards the reform of the governance of the Italian Medicines Agency and the Single Commission: where are we?

Update 20 November 2023 The extraordinary State-Regions Conference held on 16 November 2023 sanctioned the long-awaited agreement on the Minister of Health's draft regulation,